Noncontact Ultrasonic Phased-Array Promotes Hair Growth in Androgenic Alopecia Patients.

JRCT ID: jRCTs031200394

Registered date:04/03/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Androgenetic alopecia
• Date of first enrollment: 04/03/2021
• Target sample size: 20
• Study type: Interventional

Intervention(s)

Apply to the area of the scalp where the test site is shaved with an electric shaver, under the following conditions.
Apply 0.5mL of the SCALP-D Medical Minoxi 5 to the irradiated and non-irradiated areas, twice daily, and apply thoroughly with fingertips.

Outcome(s)

• Primary Outcome: Phototricogram assessment of the study site at 12 and 24 weeks (% of growing hairs)

Secondary Outcome

1. Phototrichogram evaluation of the test site (hair density, hair diameter, hair elongation, and binarization)
2. The doctor's findings on the skin of the irradiated area (bleeding, erythema, purpura, papule, nodule, erosion, ulcer)
3. Experiential questionnaire evaluation by the research subjects

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Male

Include criteria

1) Over 20 years old males who are understood the research and agreed to it.
2) 20 AGA patients (Hamilton-Norwood classification type III-vertex to V)

Exclude criteria

1) Patients undergoing treatment for AGA who have had a satisfactory response to previous treatment
2) Patients who are judged by the participating physicians to be inappropriate to conduct this study
3) Patients who have participated in another clinical trial or clinical study in the past six months

Related Information

• Primary Sponsor: Ogawa Rei
• Secondary Sponsor: Takada Hiroya,ANGFA Co., Ltd.